Is your equipment helping or hurting patient communication?
Brian Bradfield.With existing scheduling backlogs, radiology technologists are feeling the pressure to move fast. While patient volumes have swelled, staffing challenges have left a less-than-optimal workforce with a bigger workload. A critical element of care can suffer on account of this pressure: patient communication.
Effective patient communication is already a topic of concern in radiology. While there's a case for providing more training opportunities to support good patient communication, there's also a conversation to have about how the equipment used by a facility can impact patient communication and, ultimately...
Source: AuntMinnie.com Headlines - April 5, 2024 Category: Radiology Authors: Brian Bradfield Tags: Practice Management Source Type: news
Bone health appears normal in transgender youth on hormone therapy
Bone mineral density (BMD) is only slightly below the normal average among transgender youth undergoing gender-affirming hormone therapy, according to a study by researchers at the University of Colorado in Aurora.
A team of pediatricians analyzed results from dual energy x-ray absorptiometry (DEXA) scans in a group of transgender youth who participated in a trial at Children's Hospital Colorado between 2016 and 2018 to evaluate insulin sensitivity and body composition. The finding may be reassuring for youths undergoing gender-affirming care, noted lead author and medical student Micaela Roy.
“Total body BMD Z-scores ...
Source: AuntMinnie.com Headlines - April 5, 2024 Category: Radiology Authors: Will Morton Tags: Digital X-Ray Source Type: news
MRI shows preeclampsia's effect on maternal heart, fetal brain
MRI reveals the negative effects of preeclampsia on pregnant women's hearts and on the brains of their fetuses, according to research published in the April issue of Hypertension.
The results highlight MRI's benefits as a prenatal assessment tool, wrote a group led by Megan Hall, MD, of St Thomas' Hospital in London, U.K.
"As well as giving insight into the immediate pathophysiological impact of preeclampsia, [MRI] holds potential as a valuable tool for risk stratification both antenatally and when considering longer-term cardiovascular risk in women," it noted.
Preeclampsia is a disease of pregnancy that has both short...
Source: AuntMinnie.com Headlines - April 5, 2024 Category: Radiology Authors: Kate Madden Yee Tags: Clinical News Womens Imaging Ob/Gyn Source Type: news
CDL Nuclear Technologies launches mobile cardiac PET/CT trailer
CDL Nuclear Technologies has launched a mobile cardiac PET/CT trailer, the company announced.
The mobile cardiac PET/CT trailer is designed for healthcare facilities that do not have on-site advanced cardiovascular imaging capabilities, have limited access to innovative imaging tools, or are looking to expand their cardiovascular service line offerings at a lower cost, according to CDL.
The company said the new trailer complements its other services, which include PET/CT buildouts and on-demand daily use rubidium-82 radioisotope services. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 5, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Product News Molecular Imaging Industry News Source Type: news
Life Molecular Imaging, Sofie add Neuraceq availability out of Ohio
Life Molecular Imaging (LMI) and Sofie Biosciences have begun offering the Neuraceq (florbetaben F-18) PET radiotracer produced at Sofie's radiopharmaceutical manufacturing site in Cleveland, Ohio. With this expansion, LMI continues driving commercial sales of Neuraceq around the U.S. for the detection of beta-amyloid plaques in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive decline, according to the vendor. Neuraceq may also assist in assessing treatment eligibility for newly approved anti-amyloid drugs or for enrollment in clinical tri...
Source: AuntMinnie.com Headlines - April 5, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Nuclear Radiology Molecular Imaging Industry News Source Type: news
RaySearch to present at IBA ’s international meeting on proton therapy
RaySearch Laboratories will present its software at Ion Beam Applications (IBA)'s International Symposium on Proton Therapy to be held in Boston, MA, on April 5.
It also plans to present at the National Proton Conference run by the National Association on Proton Therapy in Boston between April 6 and 9.
The company's focus at both meetings will be on support for proton arcs and optimization based on linear energy transfer and adaptive therapy. RaySearch will also showcase new features in RayStation 2023B related to proton therapy and will briefly outline ongoing research and development around ConformalFLASH, spatial f...
Source: AuntMinnie.com Headlines - April 4, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
MedCognetics nabs patent for breast AI tech
Medical imaging AI developer MedCognetics has been awarded a patent for its AI technology in mammography by the U.S. Patent and Trademark Office (USPTO).
The patent covers architectural strategies and methodologies for achieving unbiased AI in breast imaging. The company highlighted that this is supported by MedCognetics’ peer-reviewed publications in industry conferences such as RSNA 2023 and the European Society of Radiology (ESR) 2024, as well as a grant from the National Institutes of Health (NIH).
The USPTO patent number for this MedCognetics entry is 11,948,297. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 4, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
RLS enters strategic agreement with Eckert & Ziegler
RLS Radiopharmacies has entered a strategic agreement with Eckert & Ziegler, which will see all 31 of RLS’s radiopharmacies equipped with Eckert & Ziegler’s GalliaPharm generators.
The RLS radiopharmacy network will use these generators to produce gallium-68-based (Ga-68) radiopharmaceuticals for PET imaging and treatment planning for patients with neuroendocrine tumors and prostate cancer.
To date, RLS has installed Eckert & Ziegler’s GalliaPharm generators within most of its locations and anticipates the remaining radiopharmacies will be operational by the end of June 2024.
RLS added that it is also building ...
Source: AuntMinnie.com Headlines - April 4, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
Siemens Healthineers gets FDA nod for Mammomat B.brilliant system
The Mammomat B.brilliant mammography platform by Siemens Healthineers has received 510(k) clearance by the U.S. Food and Drug Administration (FDA). Image courtesy of Siemens Healthineers,Siemens Healthineers' Mammomat B.brilliant mammography system has received 510(k) clearance by the U.S. Food and Drug Administration (FDA).
Mammomat B.brilliant is the first completely redesigned mammography platform in over a decade, the company said. The clearance includes elements that involve full-field digital mammography, 2D breast imaging, breast biopsy, and titanium contrast-enhanced mammography.
Additionally, Siemens recently f...
Source: AuntMinnie.com Headlines - April 4, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
Fujifilm, Brainlab partner on distribution of Arietta
Fujifilm Healthcare Americas and Brainlab have inked a partnership that sets Brainlab as the exclusive U.S. distributor of Arietta Precision Ultrasound for neurosurgery applications to be used with Brainlab's surgical navigation systems.
Brainlab will distribute Arietta Precision as a standalone product alongside and with its Ultrasound Navigation software. The company said that this offering is expected to be cleared by the U.S. Food and Drug Administration (FDA) and available in the U.S. in mid-2024. The combination of these technologies will offer neurosurgeons real-time insights through live intraoperative ultrasoun...
Source: AuntMinnie.com Headlines - April 4, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
The rise of theranostics: Part 2 -- Moving into communities
A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. That has changed and the field of theranostics is expanding rapidly in various ways, as described in part 1 of AuntMinnie.com's series on the rise of theranostics.
However, few freestanding theranostics centers exist today. Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. They're also mindful of the multiple dedicated teams required to build a thera...
Source: AuntMinnie.com Headlines - April 4, 2024 Category: Radiology Authors: Liz Carey Tags: Practice Management Radiation Oncology/Therapy Nuclear Medicine Medicolegal Genitourinary Radiology Source Type: news
Radiomics Nomograms Can Predict Cochlear, Vestibular EH in Meniere Disease
THURSDAY, April 4, 2024 -- Novel radiomics nomograms successfully predict cochlear and vestibular endolymphatic hydrops (EH) in patients with Meniere disease, according to a study published online March 8 in European Radiology.
Wei Chen, from Fudan... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 4, 2024 Category: Pharmaceuticals Source Type: news
RSNA: Early Coronary Disease, Impaired Heart Function Found in Asymptomatic People with HIV
A new study found increased coronary vessel wall thickness that was significantly associated with impaired diastolic function in asymptomatic, middle-aged individuals living with HIV. The study was published today in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 4, 2024 Category: Pharmaceuticals Tags: SVY Source Type: news
Your Doctor ’ s Words Could Make You Sick
“You may feel a sharp pinch, but it will all be over quickly.”
Before the COVID-19 jab was plunged into our arms, most of us probably heard words similar to these. After the anticipated pinch, the nurse or doctor likely told us something about possible vaccine side effects. For one of us, the nurse’s forewarning was rather specific: “Around 12 hours from now you may experience a pain in your arm or feel flu symptoms. But don’t worry,” the nurse aimed to reassure. “This can be easily managed by Tylenol.”
[time-brightcove not-tgx=”true”]
Sure enough, like clo...
Source: TIME: Health - April 4, 2024 Category: Consumer Health News Authors: Charlotte Blease, Michael Bernstein, Cosima Locher, and Walter Brown Tags: Uncategorized freelance History Source Type: news
French-led team unveils 11.7 tesla MRI scans of human brain
A research group based in Saclay, near Paris, has taken the wraps off what it claims are the world's first MRI scans of the human brain in vivo taken at a field strength of 11.7 tesla. President Emmanuel Macron has congratulated the researchers on social media.
"The first images surpassed our expectations, giving after just four minutes, mind-blowing brain images without any artifacts, with superb tissue contrast and resolution, which represents a volume equivalent to a few thousand neurons," Denis Le Bihan, PhD, founding director of the NeuroSpin research facility and founder of Iseult Project of the French Alternative E...
Source: AuntMinnie.com Headlines - April 4, 2024 Category: Radiology Authors: Philip Ward Tags: MRI Source Type: news
